ATI-2341 is primarily utilized in medical research due to its role as a selective agonist of the CXCR4 receptor. This receptor is involved in various physiological processes, including immune response, stem cell migration, and cancer metastasis. In research settings, ATI-2341 is used to study these processes, particularly in understanding how CXCR4 signaling pathways influence disease progression. It is also explored for its potential in mobilizing hematopoietic stem cells from bone marrow into the bloodstream, which can be crucial for stem cell transplantation therapies. Additionally, ATI-2341 is investigated for its potential therapeutic applications in conditions like cancer, where CXCR4 plays a significant role in tumor growth and spread. Its ability to modulate CXCR4 activity makes it a valuable tool in both basic science and drug development research.